GLP-1 (S) is a synthetic peptide analog derived from the glucagon-like peptide-1 (GLP-1) framework and engineered with targeted structural modifications. Supplied as a lyophilized powder for in vitro research involving incretin signaling, receptor interactions, and peptide stability studies.